The burden of severe hypoglycemia in type 1 diabetes.

Jieruo LiuRosa WangMichael L GanzYurek PaprockiDoron SchneiderJames Weatherall

Published in: Current medical research and opinion (2017)

The burden associated with SHO is not negligible. About 4% of T1DM patients using basal-bolus insulin regimens are hospitalized at least once due to SHO. Not only did those patients incur the costs of their SHO hospitalization, but they also incur red at least $712 (52%) more in costs per month after their hospitalization than outpatient SHO or comparison patients. Reducing SHO events can help decrease the burden associated with SHO among patients with T1DM.

Keyphrases

type diabetes
end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
glycemic control
patient reported outcomes
metabolic syndrome
risk factors
skeletal muscle
insulin resistance
patient reported